Parkinson’s disease

Dec 04, 2020

According to the International Neuromodulation Society, neuromodulation is "the alteration—or modulation—of nerve activity by delivering electrical or pharmaceutical agents directly to a target area". The neuromodulation space is witnessing one of the fastest-growing medical device markets in the healthcare industr...

Oct 19, 2020

Neurodegenerative diseases affect millions of people worldwide. And with the world demographics getting older, it is apt to foretell that the burden of neurodegenerative disorders is expected to mount. With advances in medical technology, the life expectancy of people has drastically increased, reeling people to an...

Jul 22, 2019

Parkinson’s Disease is a condition that involves dysfunction or loss of dopamine-producing neurons in the brain. The hallmarks of this Disease are degeneration of dopaminergic neurons in the substantia nigra pars compacta of the midbrain and Lewy bodies presence, cytoplasmic aggregations of the protein a-synuclein ...

Apr 29, 2019

Parkinson's Awareness Month April marks Parkinson's Awareness Month, is an occasion to spread awareness about Parkinson’s. Not the early signs as they are more than just any tremor! Parkinson’s changes everything. Over 10 Million people are living with Parkinson’s worldwide yet the condition remains a mystery. ...

Apr 22, 2019

Parkinson's Disease (PD) is a chronic and progressive movement disorder which primarily affects dopamine-producing (“dopaminergic”) neurons in a specific area of the brain called substantia nigra.  These neurons are usually responsible for the control and coordination process, which during the neuron malfuncti...

Mar 20, 2019

The Cornea- the outermost layer in the human eye, plays an important role in regulating the amount of light entering into the eye. It also protects the eye from germs, dust, and other harmful matter. Although this important part of the human body has a countless number of ways to get damaged. Corneal Abrasions, Dry...

Sep 18, 2018

Argenx gets green cue in phase 2 in primary immune thrombocytopenia The Belgian biotech, Argenx has cleared phase 2 data on efgartigimod in primary immune thrombocytopenia (ITP). The results that they received, indicate at the effectiveness of the antibody Fc fragment in patients with the autoimmune bleeding disord...

Aug 17, 2018

Diverse voltage and ligand gated ion channels mediate Neuron excitation through various ions by sending electrical signals. Calcium is critical for cellular functioning. Voltage-gated calcium channels are primary mediators of depolarization-induced calcium entry into neurons. Calcium ions act as membrane potentiatio...

Aug 01, 2018

‘Reprogrammed’ stem cells to be tested in people with Parkinson’s Doctors in Japan are poised to implant neural cells made from ‘reprogrammed’ stem cells into the brains of people with Parkinson’s disease. It is only the third clinical application of induced pluripotent stem (iPS) cells, which are developed by repro...

Aug 31, 2017

Japanese researchers report promising results from an experimental therapy for Parkinson’s disease that involves implanting neurons made from ‘reprogrammed’ stem cells into the brain. A trial conducted in monkeys with a version of the disease showed that the treatment improved their symptoms and seemed to be safe, a...